Concepedia

Kathleen Weisel

KW

7

Publications

527

Citations

7

H-Index

2013

Active since

Affiliations

GlaxoSmithKline (United States)(Current)

GlaxoSmithKline (United Kingdom)

Medical University of Vienna

University of California San Diego

Western University

Kathleen Weisel is an author at GlaxoSmithKline (United States) specializing in medicine, urology, and renal disease.

Top concepts

Publications per year

2013–2022

7

Publications

7

Guselkumab for the Treatment of Crohn’s Disease: Induction Results From the Phase 2 GALAXI-1 Study

William J. Sandborn, Geert D’Haens, Walter Reinisch et al. · Gastroenterology · 2022 · 188 citations · Full text

Randomized clinical study of safety, pharmacokinetics, and pharmacodynamics of <scp>RIPK</scp>1 inhibitor <scp>GSK</scp>2982772 in healthy volunteers

Kathleen Weisel, Nicola Scott, Debra Tompson et al. · Pharmacology Research & Perspectives · 2017 · 123 citations · Full text

A randomized, placebo-controlled experimental medicine study of RIPK1 inhibitor GSK2982772 in patients with moderate to severe rheumatoid arthritis

Kathleen Weisel, Scott B. Berger, Katie Thorn et al. · Arthritis Research & Therapy · 2021 · 83 citations · Full text

Response to Inhibition of Receptor‐Interacting Protein Kinase 1 (RIPK1) in Active Plaque Psoriasis: A Randomized Placebo‐Controlled Study

Kathleen Weisel, Scott B. Berger, Kim Papp et al. · Clinical Pharmacology & Therapeutics · 2020 · 71 citations · Full text

Effect of PSI‐697, a Novel P‐Selectin Inhibitor, on Platelet–Monocyte Aggregate Formation in Humans

Alan G. Japp, Raj Chelliah, Laura Tattersall et al. · Journal of the American Heart Association · 2013 · 32 citations · Full text

Rows per page

1–5 of 7